| Join | Site Map | Contact | Home
General Information Meeting Agenda Abstracts Exhibits Sponsors Registration Hotel & Travel

 

 

 

On-line
Registration Kit

Transgenic and In Vivo Mutagenesis
Special Interest Group

Breakfast Meeting Agenda

Sunday, October 24, 2010

7:00 AM–8:30 AM

Breakfast Meeting

Transgenic and In Vivo Mutagenesis

Leaders: Kathleen A. Hill, The University of Western Ontario and
Mugimane Manjanatha, National Center for Toxicological Research, U.S. FDA

7:00 AM–7:30 AM

Breakfast
General Introduction
Nominations and Elections for Chair and Co-Chair TIVM SIG 2010–2011
Circulate Membership List Update
New Business

7:15 AM–7:30 AM

Integration of Pig-a, Micronucleus, Chromosome Aberration, and Comet Assay Endpoints in a 28-Day Rodent Toxicity Study with 4-nitroquinoline-1-oxide (4NQO)
(Poster 99)
Leon Stankowski, Covance Laboratories, Inc.

7:30 AM–7:45 AM

Measuring DNA Damage in 3D Human Skin Models Using the Comet Assay
(Poster 102)
Tom Downs, Procter & Gamble Co.

7:45 AM–8:00 AM

Searching for New Markers of Instability in the Germline of Mice: Are Simple Tandem Repeats (STR) the Needle in the Haystack?
(Poster 84)
Marc Beal,University of Regina

8:00 AM–8:15 AM

AZT is Predominately Clastogenic, Not Mutagenic, Results from a Seven Day Study in Rats
Andreas Zeller, Hoffmann-La Roche Ltd.

8:15 AM–8:30 AM

Acrylamide and Glycidamide Induce cII Mutations in the Testes of Big Blue Mice
Nan Mei, National Center for Toxicological Research, U.S. FDA

8:30 AM

Adjourn